U.S. market Closed. Opens in 1 day 12 hours 24 minutes

LEXXW | Lexaria Bioscience Corp. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2024-08-312023-08-312022-08-312021-08-312020-08-312019-08-312018-08-312017-08-312016-08-312015-08-312014-08-312012-10-312011-10-312010-10-312009-10-312008-10-312007-10-312006-10-312005-10-31
Revenue464.28K226.21K255.40K722.74K384.54K222.61K433.29K63.64K40.72K14.70K1.10M1.36M1.13M362.47K421.95K900.79K253.15K20.31K20.31K
Cost of Revenue4.82K31.50K71.84K175.35K99.38K22.89K25.18K29.75K45.62K29.88K795.20K783.27K667.86K273.62K548.32K912.75K124.91K93.32K93.32K
Gross Profit459.46K194.71K183.56K547.39K285.17K199.72K408.10K33.89K-4.90K-15.18K302.25K574.49K465.91K88.86K-126.37K-11.96K128.24K-73.01K-73.01K
Operating Expenses6.21M6.73M7.57M6.23M4.27M4.26M7.01M1.90M1.21M1.91M8.19K579.40K725.41K474.00K467.18K480.72K1.18M138.53K35.14K
Selling, General & Admin3.85M3.06M5.72M4.97M3.77M3.64M6.51M1.84M1.20M1.76M8.19K565.35K719.01K467.23K458.97K479.45K1.03M141.51K35.14K
Research & Development2.36M3.67M1.84M1.26M387.07K555.73K492.86K54.19K9.02K146.47KN/AN/AN/AN/AN/AN/AN/AN/AN/A
Other Operating ExpensesN/AN/AN/AN/A112.75K60.55K2.31K-886.004.60K-22.66KN/A14.04K6.40KN/A8.21K1.27K148.38K-2.99KN/A
Operating Income-5.75M-6.53M-7.38M-5.69M-3.89M-3.96M-6.60M-1.86M-1.22M-1.93M294.06K-4.90K-259.50K-552.46K-753.67K-898.09K-1.05M-489.66K-35.14K
Other Expenses / Income-55.52K-178.50K-764.61K1.52MN/A-228.06K-8.97K-6.01K-34.70K-55.06K-355.23K-246.61K-276.22K-278.73KN/A7.05K-73.27K-565.19K-473.12K
Before Tax Income-5.81M-6.71M-7.38M-4.16M-4.08M-4.16M-6.61M-1.93M-1.28M-1.98M-1.87M-251.51K-538.23K-552.46K-753.67K-971.35K-1.05M-211.54K-75.58K
Income Tax ExpensesN/AN/A-114.33K-1.66M-54.29K39.62K-8.97K-54.17K-60.23K-181.23K294.06K246.61K278.73K167.32K-94.007.14K1.04K574.84K40.59K
Net Income-5.80M-6.66M-7.27M-2.50M-4.03M-4.20M-6.60M-1.87M-1.21M-1.77M-1.87M-251.51K-538.23K-552.46K-753.57K-978.49K-1.06M-508.26K-75.72K
Interest ExpensesN/AN/AN/AN/AN/AN/AN/A6.01K2.25K31.54K267.36K246.61K278.73K167.32K160.12K857.58K4.71K21.91K21.91K
Basic Shares Outstanding12.38M6.61M5.89M4.39M2.77M2.59M2.37M1.96M1.46M1.32M25.71M602.48K493.23K451.94K268.67K219.28K202.59K160.87K55.15K
Diluted Shares Outstanding12.38M6.61M5.89M4.39M2.77M2.59M2.37M1.96M1.46M1.32M25.71M602.48K493.23K451.94K268.67K219.28K202.59K160.87K55.15K
EBITDA-5.68M-6.39M-6.52M-5.58M-4.00M-4.10M-6.61M-1.92M-1.26M-1.95M294.06K-35.30K442.73K111.12K-236.15K-244.37K-414.37K-891.03K-129.78K
EBITDA Margin-1,222.75%-2,824.23%-2,551.45%-771.39%-1,040.90%-1,840.83%-1,524.83%-3,020.10%-3,091.99%-13,269.46%26.79%-2.60%39.05%30.66%-55.97%-27.13%-163.69%-4,387.80%-639.09%
EBIT-5.80M-6.66M-7.38M-4.16M-4.08M-4.16M-6.61M-1.92M-1.27M-1.92M-1.31M241.70K19.22K-217.82K-593.55K-113.77K-1.05M88.49K-13.23K
EBIT Margin-1,248.25%-2,946.36%-2,891.05%-576.16%-1,062.20%-1,868.03%-1,525.04%-3,012.99%-3,125.77%-13,060.69%-119.35%17.80%1.70%-60.09%-140.67%-12.63%-414.83%435.76%-65.14%
Financial Year End2024-08-312023-08-312022-08-312021-08-312020-08-312019-08-312018-08-312017-08-312016-08-312015-08-312014-08-312012-10-312011-10-312010-10-312009-10-312008-10-312007-10-312006-10-312005-10-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙